Uptake of Dietary Sodium Restriction by Overweight and Obese Patients After Cardiac Revascularization.
Uptake of Dietary Sodium Restriction by Overweight and Obese Patients After Cardiac Revascularization.
复制标题
心脏血运重建后超重和肥胖患者限制饮食钠的摄入。
DOI:
10.1002/rnj.205
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Barnason,Susan
中科院分区:
文献类型:
--
作者:
Young,Lufei;Barnason,Susan
Purpose:High sodium intake increases the risk of cardiovascular diseases. Cardiac patients are recommended a daily sodium restriction of≤ 1,500 mg. The purpose of this article is to describe daily sodium intake and sodium restriction adherence and its correlates in cardiac rehabilitation (CR) program participants following cardiac revascularizations.Design:This is a descriptive correlational study.Methods:A subanalysis was performed using the data collected from a randomized controlled trial to determine the effect of a 12-week weight management intervention.Findings:The average daily sodium intake was 3,020 mg±1,134 at baseline, 4,047 mg±1,517 at 4 months, and 4,399 mg±1,722 at 6 months. The adherence rates were 4.8% at baseline and zero at 4 and 6 months. The factors influencing daily sodium intake were identified.Conclusion:The CR program participants failed to adhere to the sodium restriction guidelines.Clinical relevance:Rehabilitation nurses need to identify effective strategies to educate CR participants and their family members regarding dietary sodium adherence in CR participants.BackgroundThe adverse effects of high sodium intake on morbidity and mortality in people with established cardiovascular disease (CVD) is well documented (Celermajer & Neal, 2013; Mc Causland, Waikar, & Brunelli, 2012; Strazzullo, D'Elia, Kandala, & Cappuccio, 2009; Taylor, Ashton, Moxham, Hooper, & Ebrahim, 2011). Decreased sodium intake reduces subsequent cardiovascular events by as much as 25%(Cook et al., 2007). In a long-term clinical trial, a low sodium intake independently reduced cardiovascular morbidity and mortality (Middeke, 2012). Experimental studies have demonstrated an independent dose–response relationship between sodium intake and blood pressure, a leading risk factor for CVD (Cook, Kumanyika, Cutler, Whelton, & Trials of Hypertension Prevention Collaborative Research Group 2005; Lin et al., 2007; Rambod & Tolouian, 2012; Sacks et al., 2001). When patients with hypertension and prehypertension decreased daily sodium intake to less than 2,300 mg over a 12-to 48-month period, they reduced their systolic blood pressure by 1.2–3.7 mmHg and diastolic blood pressure by 0.7–2.0 mmHg (Trials of Hypertension Prevention Collaborative Research Group, 1997; Appel et al., 2001; China Salt Substitute Study Collaborative Group, 2007; Kumanyika et al., 1993; Lasser et al., 1995).